Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02115, USA.
Sci Immunol. 2024 Mar 8;9(93):eadf2223. doi: 10.1126/sciimmunol.adf2223.
T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) is an important immune checkpoint molecule initially identified as a marker of IFN-γ-producing CD4 and CD8 T cells. Since then, our understanding of its role in immune responses has significantly expanded. Here, we review emerging evidence demonstrating unexpected roles for TIM-3 as a key regulator of myeloid cell function, in addition to recent work establishing TIM-3 as a delineator of terminal T cell exhaustion, thereby positioning TIM-3 at the interface between fatigued immune responses and reinvigoration. We share our perspective on the antagonism between TIM-3 and T cell stemness, discussing both cell-intrinsic and cell-extrinsic mechanisms underlying this relationship. Looking forward, we discuss approaches to decipher the underlying mechanisms by which TIM-3 regulates stemness, which has remarkable potential for the treatment of cancer, autoimmunity, and autoinflammation.
T 细胞免疫球蛋白和黏蛋白结构域蛋白 3(TIM-3)是一种重要的免疫检查点分子,最初被鉴定为 IFN-γ 产生的 CD4 和 CD8 T 细胞的标志物。从那时起,我们对其在免疫反应中的作用的理解有了显著的扩展。在这里,我们综述了新出现的证据,证明 TIM-3 作为髓样细胞功能的关键调节剂的意想不到的作用,此外,最近的工作还确立了 TIM-3 作为终末 T 细胞衰竭的标志物,从而将 TIM-3 定位在疲劳的免疫反应和复苏之间的界面上。我们分享了我们对 TIM-3 和 T 细胞干性之间拮抗作用的观点,讨论了这种关系的内在和外在机制。展望未来,我们讨论了解 TIM-3 调节干性的潜在机制的方法,这对于癌症、自身免疫和自身炎症的治疗具有显著的潜力。